The patient with diabetes mellitus and heart failure: at-risk issues.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  American Journal of Medicine

• Publication date

  2003-12-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AMJMED.2003.09.017PMID 14678875
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rosiglitazone reduces urinary albumin excretion in type II diabetes

  2003cited by this paper
• Differentiation of the metabolic and vascular effects of insulin in insulin resistance in patients with chronic heart failure.

  2002cited by this paper
• Oral antihyperglycemic therapy for type 2 diabetes: scientific review.

  2002cited by this paper
• Effect of rosiglitazone on insulin sensitivity and body composition in type 2 diabetic patients [corrected].

  2002cited by this paper
• The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes.

  2002cited by this paper
• A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes.

  2002cited by this paper
• Pioglitazone Improves Left Ventricular Diastolic Function and Decreases Collagen Accumulation in Prediabetic Stage of a Type II Diabetic Rat

  2001cited by this paper
• Nonhypoglycemic Effects of Thiazolidinediones

  2001cited by this paper
• Endothelial dysfunction in chronic heart failure: clinical implications and therapeutic options.

  2001cited by this paper
• Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides.

  2001cited by this paper
• Rapid communication: inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes.

  2001cited by this paper
• Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia.

  2001cited by this paper
• Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study.

  2001cited by this paper
• Insulin resistance and cardiovascular disease.

  2000cited by this paper
• Defects in insulin action in chronic heart failure

  2000cited by this paper
• Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model.

  2000cited by this paper
• Insulin resistance in chronic heart failure.

  2000cited by this paper
• Hemostatic abnormalities in patients with congestive heart failure: diagnostic significance and clinical challenge.

  2000cited by this paper
• Safety and tolerability of pioglitazone

  2000cited by this paper
• Prognostic importance of insulin-mediated glucose uptake in aged patients with congestive heart failure secondary to mitral and/or aortic valve disease.

  1999cited by this paper
• Interaction between Insulin and AT1 receptor. Relevance for hypertension and arteriosclerosis

  1998cited by this paper
• Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes.

  1998cited by this paper
• Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure.

  1997cited by this paper
• Cardiac and Glycemic Benefits of Troglitazone Treatment in NIDDM

  1997cited by this paper
• Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system.

  1996cited by this paper
• Cardiac consequences of diabetes mellitus

  1995cited by this paper
• Insulin resistance in chronic heart failure.

  1994cited by this paper
• Pathogenesis of NIDDM: A Balanced Overview

  1992cited by this paper
• Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure.

  1991cited by this paper
• Myocardial disease in hypertensive-diabetic patients.

  1989cited by this paper

• DASH Diet Versus Intermittent Fasting on Insulin Resistance in NAFLD Patients

  2024cites this paper
• References

  2021cites this paper
• Clinical Management of Intermittent Fasting in Patients with Diabetes Mellitus

  2019cites this paper
• Cardioprotective effect of 6-shogaol against hyperglycemia-induced toxicity in H9c2 cardiomyocytes via suppressing of NF-κB pathway.

  2019cites this paper
• Peri-mortem disease treatment: a little known cause of error in the estimation of the time since death in decomposing human remains

  2016cites this paper
• HDAC Inhibition Modulates Cardiac PPARs and Fatty Acid Metabolism in Diabetic Cardiomyopathy

  2016cites this paper
• Disparities in Heart Failure and other Cardiovascular Diseases among Women

  2012cites this paper
• High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes

  2012cites this paper
• EFEITOS DA OOFORECTOMIA E DO DESIDROEPIANDROSTERONA (DHEA) SOBRE A MASSA CARDÍACA DE RATAS.

  2012cites this paper
• Autophagy contributes to retardation of cardiac growth in diabetic rats

  2012cites this paper
• Occurrence, complications, and interventions of diabetes: A new understanding of an old problem

  2011cites this paper
• Morfometria das fibras colágeno cardíaco em ratos sadios e diabéticos suplementados com vitamina C

  2011cites this paper
• Structural arrangement of the cardiac collagen fibers of healthy and diabetic dogs

  2011cites this paper
• Prevalence, clinical characteristics and outcome in patients with chronic heart failure and diabetes.

  2010cites this paper
• Assessing the potential for outcome reporting bias in a review: a tutorial

  2010cites this paper
• Ultrastructural changes in the glomerular filtration barrier and occurrence of proteinuria in Chinese patients with type 2 diabetic nephropathy.

  2009cites this paper
• Sarcolemmal fatty acid uptake vs. mitochondrial beta-oxidation as target to regress cardiac insulin resistance.

  2009cites this paper
• Sex differences in use of interventional cardiology persist after risk adjustment

  2008cites this paper
• Adverse drug reactions in patients with cardiovascular disease.

  2008cites this paper
• Insulin Resistance: The Cardiovascular Aspect

  2008cites this paper
• THE EFFECTS OF THIAZOLIDINEDIONE THERAPY ON NT-PROBNP LEVELS IN PATIENTS WITH TYPE 2 DIABETES

  2008cites this paper
• Cardiac Metallothionein Induction Plays the Major Role in the Prevention of Diabetic Cardiomyopathy by Zinc Supplementation

  2008cites this paper
• RENAL B-MOD ULTRASONOGRAFİ BULGULARININ DİABETİK NEFROPATİ EVRESİ İLE İLİŞKİSİ

  2008cites this paper
• Daily Variability in Dyspnea, Edema and Body Weight in Heart Failure Patients

  2007cites this paper
• From the pancreatic beta cell to the endothelium:Pathophysiological aspects of Type 2 Diabetes

  2007cites this paper
• , Amelia Cardiac Development and Function Growth Factor 1 Receptor Signaling in Essential Role of Insulin and Insulin-Like

  2007cites this paper
• Echocardiography findings in patients with ST segment elevation myocardial infarction and type 2 diabetes mellitus treated with primary percutaneous coronary angioplasty

  2006influential citation
• Essential Role of Insulin and Insulin-Like Growth Factor 1 Receptor Signaling in Cardiac Development and Function

  2006cites this paper
• A case of ACTH-independent bilateral macronodular adrenal hyperplasia and severe congestive heart failure

  2006cites this paper
• [Diabetic miocardiopathy].

  2006cites this paper
• Insuficiencia cardíaca y diabetes

  2006cites this paper
• Cardiac Metallothionein Induction Plays the Major Role in the Prevention of Diabetic Cardiomyopathy by Zinc Supplementation

  2006cites this paper
• Arg-Gly-Asp (RGD)-containing peptides increase soluble guanylate cyclase in contractile cells.

  2006cites this paper
• Echokardiograficzne zmiany u chorych na cukrzycę typu 2 po przebytym zawale serca z uniesieniem odcinka ST, leczonych pierwotną przezskórną angioplastyką wieńcową

  2006cites this paper
• Phospholipid-mediated signaling in diseased myocardium

  2006cites this paper
• Influence of glycemic control on pulmonary function and heart rate in response to exercise in subjects with type 2 diabetes mellitus.

  2006cites this paper
• Heart failure, diabetes and the thiazolidinediones: an unfolding story

  2005cites this paper
• Effects of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart.

  2005cites this paper
• Diabetic Cardiomyopathy : Evidences , Pathophysiology , and Therapeutic Considerations

  2005cites this paper
• Massive oedema in a Cape Verde sailor.

  2005cites this paper
• The Metabolic Syndrome and Inflammation

  2004cites this paper
• Thirty-Day Analysis of Dyspnea and Edema in Heart Failure Subjects

  2004influential citation
• Type 2 Diabetes and Chronic Systolic Heart Failure: Clinical Implications

  2004cites this paper
• Diabetes mellitus and heart failure: basic mechanisms, clinical features, and therapeutic considerations.

  2004cites this paper
• Introduction and summary statements

  2003cites this paper
• Microalbuminuria in insulin-dependent diabetes mellitus always indicative of diabetic nephropathy?

  2003cites this paper
• Departamento de Fisiologia

  2002cites this paper